The major factors for the growth of the hemodialysis market include the rising number of end-stage renal disease (ESRD) patients and the increasing incidence of diabetes and hypertension.
The rise in the number of ESRD and shortage in the availability of kidneys for transplant expected to boost the growth of the market. Chronic kidney disease (CKD) is a condition that causes reduced kidney function over a period of time. It may develop over many years and lead to end-stage kidney (or renal) disease (ESRD). It has become an enormous public health issue that continues to rise.
As per the estimation by the Global Burden of Disease Study, kidney disease was the 12th-most common cause of death, accounting for 1.1 million deaths worldwide in 2015. Furthermore, as per the 2016 report on Diabetes and Chronic Kidney Disease, Diabetes causes 44% of all new cases of kidney failure. Thus, owing to the rising burden of kidney failures there will be a huge demand for hemodialysis equipment resulting in high growth of the market.
Key Market Trends
Conventional Long-Term Hemodialysis is the Segment by Modality expected to hold Largest Market Share over the Forecast Period
The hemodialysis market is segmented by Modality in three major segments Conventional Long-Term Hemodialysis, Short Daily Hemodialysis, and Nocturnal hemodialysis. The Conventional Long-Term Hemodialysis is expected to hold a large market share owing to the huge acceptance of hemodialysis therapy over peritoneal dialysis among CKD and ESRD patients.
According to the Organ Procurement and Transplantation Network around 83.7% of people are waiting for kidney transplants. Thus, owing to the shortage of kidneys for transplant the market is expected to witness high growth.
North America is Expected to Hold Largest Market Share over the Forecast Period
The United States is expected to be the largest market for hemodialysis owing to the presence of better healthcare infrastructure and the presence of major market players. As per the Center for disease control and prevention, 15% of US adults or 37 million people are estimated to have chronic kidney disease common in people aged 65 years or older (38%) than in people aged 45–64 years (13%) or 18–44 years.
According to the Population Reference Bureau, the number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. An aging population and growing risk of chronic kidney disease projected to significantly boost regional growth.
The market studied is a moderately consolidated market owing to the presence of few market players. Some of the market players are Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cantel Medical Corp., DaVita Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic PLC, Nipro Corporation, and NxStage Medical, Inc.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support